文献速递间质性肺疾病呼吸道感染

疑似电子烟或雾化产品使用相关肺损伤(EVALI)病例的病理学发现:病例系列

Pathological findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury (EVALI): a case series.
PubMed 文献 · Lancet Respir Med · 2020-08-04

该病例系列分析了美国CDC收到的10例肺活检和13例尸检组织,来自16个州疑似EVALI的个体。所有10例活检均显示急性至亚急性肺损伤的组织学证据,69%的尸检病例也可见类似模式,最常见为弥漫性肺泡损伤。研究提示,有电子烟使用史且无其他明确病因者若出现急性至亚急性肺损伤,应高度考虑EVALI。

要点

  • 所有10例肺活检均显示急性至亚急性肺损伤,包括弥漫性肺泡损伤或机化性肺炎。
  • 13例尸检中9例(69%)可见类似肺损伤模式,最常见为弥漫性肺泡损伤(8例)。
  • 部分尸检发现其他病理(如支气管肺炎、慢性间质性肺病),有助于鉴别诊断。

核心结论

  • 疑似EVALI个体的肺活检和多数尸检肺组织均可见急性至亚急性肺损伤模式。
  • 有电子烟使用史且无其他明确病因者出现急性至亚急性肺损伤,应高度考虑EVALI诊断。
  • 尸检组织病理学审查可识别替代诊断,提高公共卫生监测的特异性。

研究设计与样本

  • 样本来自16个州,个体有电子烟或雾化产品使用史,并有呼吸、胃肠或全身症状,或影像学浸润/阴影,或不明原因猝死。
  • 研究回顾了医疗记录,评估了组织病理学,并在有指征时进行了感染性疾病检测。

主要发现

  • 21例符合EVALI监测病例定义,另有2例临床疑似EVALI被评估。
  • 所有10例肺活检显示急性至亚急性肺损伤的组织学证据,包括弥漫性肺泡损伤或机化性肺炎。
  • 13例尸检中9例(69%)可见上述模式,最常见为弥漫性肺泡损伤(8例尸检),另1例为急性和机化性纤维素性肺炎。
  • 其余尸检可见不一定符合EVALI的肺部病理,包括支气管肺炎、支气管吸入和慢性间质性肺病。
  • 5例尸检无急性肺损伤证据或存在合理替代病因,其中3例曾被分类为确诊或可能EVALI。

临床怎么用

  • 对有电子烟或雾化产品使用史且无其他明确病因的急性至亚急性肺损伤患者,应高度考虑EVALI。
  • 尸检组织病理学审查有助于识别替代诊断,提高EVALI监测的特异性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since August, 2019, US public health officials have been investigating a national outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI). A spectrum of histological patterns consistent with acute to subacute lung injury has been seen in biopsies; however, autopsy findings have not been systematically characterised. We describe the pathological findings in autopsy and biopsy tissues submitted to the US Centers for Disease Control and Prevention (CDC) for the evaluation of suspected EVALI. METHODS: Between Aug 1, 2019, and Nov 30, 2019, we examined lung biopsy (n=10 individuals) and autopsy (n=13 individuals) tissue samples received by the CDC, submitted by 16 US states, from individuals with: a history of e-cigarette, or vaping, product use; respiratory, gastrointestinal, or constitutional symptoms; and either pulmonary infiltrates or opacities on chest imaging, or sudden death from an undetermined cause. We also reviewed medical records, evaluated histopathology, and performed infectious disease testing when indicated by histopathology and clinical history. FINDINGS: 21 cases met surveillance case definitions for EVALI, with a further two cases of clinically suspected EVALI evaluated. All ten lung biopsies showed histological evidence of acute to subacute lung injury, including diffuse alveolar damage or organising pneumonia. These patterns were also seen in nine of 13 (69%) autopsy cases, most frequently diffuse alveolar damage (eight autopsies), but also acute and organising fibrinous pneumonia (one autopsy). Additional pulmonary pathology not necessarily consistent with EVALI was seen in the remaining autopsies, including bronchopneumonia, bronchoaspiration, and chronic interstitial lung disease. Three of the five autopsy cases with no evidence of, or a plausible alternative cause for acute lung injury, had been classified as confirmed or probable EVALI according to surveillance case definitions. INTERPRETATION: Acute to subacute lung injury patterns were seen in all ten biopsies and most autopsy lung tissues from individuals with suspected EVALI. Acute to subacute lung injury can have numerous causes; however, if it is identified in an individual with a history of e-cigarette, or vaping, product use, and no alternative cause is apparent, a diagnosis of EVALI should be strongly considered. A review of autopsy tissue pathology in suspected EVALI deaths can also identify alternative diagnoses, which can enhance the specificity of public health surveillance efforts. FUNDING: US Centers for Disease Control and Prevention.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Reagan-Steiner S, Gary J, Matkovic E, et al. Pathological findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury (EVALI): a case series. Lancet Respir Med. 2020. PMID: 32763198. doi:10.1016/S2213-2600(20)30321-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。